Chuan Yan

14 Science Drive 4
Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcoma.

MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcoma.

Journal: Nature communications

Published: March 27, 2025

The PIK3CA/AKT pathway drives therapy resistance in rhabdomyosarcoma.

The PIK3CA/AKT pathway drives therapy resistance in rhabdomyosarcoma.

Journal: Nature communications

Published: October 16, 2024

Retraction: Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish.

Retraction: Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish.

Journal: Oncotarget

Published: May 14, 2024

Retraction notice to Corrigendum to "Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/integrin αvβ5 in zebrafish" Neoplasia 33(2022) 100831.

Retraction notice to Corrigendum to "Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/integrin αvβ5 in zebrafish" Neoplasia 33(2022) 100831.

Journal: Neoplasia (New York, N.Y.)

Published: May 05, 2024

Correction: Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.

Correction: Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy.

Journal: Cancer research

Published: May 02, 2024

Retraction notice to Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/integrin αvβ5 in zebrafish, NEO 20 (2018) 533-542.

Retraction notice to Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/integrin αvβ5 in zebrafish, NEO 20 (2018) 533-542.

Journal: Neoplasia (New York, N.Y.)

Published: April 28, 2024

The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies.

The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies.

Journal: Science advances

Published: March 01, 2024

Retraction Note: Chemical inhibition reveals differential requirements of signaling pathways in krasV12- and Myc-induced liver tumors in transgenic zebrafish.

Retraction Note: Chemical inhibition reveals differential requirements of signaling pathways in krasV12- and Myc-induced liver tumors in transgenic zebrafish.

Journal: Scientific reports

Published: November 29, 2023

Neutralizing antibodies to block viral entry and for identification of entry inhibitors.

Neutralizing antibodies to block viral entry and for identification of entry inhibitors.

Journal: Antiviral research

Published: October 31, 2023

Correction: Rapid Analysis of Effects of Environmental Toxicants on Tumorigenesis and Inflammation Using a Transgenic Zebrafish Model for Liver Cancer.

Correction: Rapid Analysis of Effects of Environmental Toxicants on Tumorigenesis and Inflammation Using a Transgenic Zebrafish Model for Liver Cancer.

Journal: Marine biotechnology (New York, N.Y.)

Published: September 28, 2023

Author Correction: Activation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish.

Author Correction: Activation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish.

Journal: Scientific reports

Published: May 31, 2023

Corrigendum to "Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/ integrin αvβ5 in zebrafish" Neoplasia 20(5):533-542.

Corrigendum to "Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/ integrin αvβ5 in zebrafish" Neoplasia 20(5):533-542.

Journal: Neoplasia (New York, N.Y.)

Published: September 29, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026